Dr. Airie Kim, MD

Dr. Kim practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Kim's NPI, 1386662807, was assigned on July 17, 2006. Dr. Kim graduated from Baylor College Of Medicine in 2004. Dr. Kim holds California license A99799.

Dr. Kim's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Kim's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kim is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kim's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia and tobacco use among the conditions Dr. Kim treats.

CMS data shows 282 Medicare services from Dr. Kim across 5 procedure codes in 2024, for 86 Medicare patients. Medicare paid $32,545 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 86 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 51% are also on Medicaid. Their average risk score is 4.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 62, with 53% women.

In 2024, Dr. Kim wrote 146 Medicare Part D claims for 25 patients. 55% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $13,341 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kim for performance year 2024, reported as part of a group. Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Dmand AI links 9 papers to Dr. Kim, published from 2013 to 2025. 2015 was the busiest year, with 3. Dr. Kim has published most often in J Minim Invasive Gynecol. Dr. Kim's most frequent co-authors are Melissa Marie Gutierrez, MD, Jasmine Pedroso, MD and Chirisse Francisca Taylor, MD.

CMS Open Payments shows 2 general payments to Dr. Kim from 2 drug and device companies from 2021 to 2025. Honoraria make up the largest share, 99% of the total. Pharmacosmos Therapeutics Inc. paid the most, $3,000.

Dmand AI lists 1 award for Dr. Kim, most recently CMS Stage 1 EHR in 2013.

Dr. Kim graduated from Baylor College Of Medicine in 2004.

Dr. Kim is in network with 12 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.